PolyPeptide Group AG PLYGF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Samsung Biologics' $2 Billion Rights Offering Oversubscribed
Samsung Biologics Seeks to Raise Over $2 Billion to Fund PolyPeptide Deal, Expansion — Update
Samsung Biologics to Buy PolyPeptide Group for About $2 Billion
Samsung Biologics Offers to Buy PolyPeptide for Around $1.8 Billion
PolyPeptide Group Shares Climb After Report of Takeover Interest
Trading Information
- Previous Close Price
- $54.42
- Day Range
- $49.00–49.00
- 52-Week Range
- $31.50–54.42
- Bid/Ask
- $0.00 / $249.83
- Shares Outstanding
- 33.01M
- Market Cap
- $1.62B
- Volume/Avg
- 100 / 100
Key Statistics
- Price/Earnings (Normalized)
- 46.90
- Price/Sales
- 2.91
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
PolyPeptide Group AG is an independent contract development and manufacturing organization (CDMO) focused on peptides and oligonucleotides employed as an active pharmaceutical ingredients (APIs) and used as intermediates in therapeutic products. The company derives majority of its revenue from Europe and Asia.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Growth
- Total Number of Employees
- 1,460
- Website
- https://www.polypeptide.com
Valuation
Metric | PLYGF |
|---|---|
Price/Earnings (Normalized) | 46.90 |
Price/Book Value | 4.03 |
Price/Sales | 2.91 |
Price/Cash Flow | 16.97 |
Price/Earnings
PLYGF
Financial Strength
Metric | PLYGF |
|---|---|
Quick Ratio | 0.76 |
Current Ratio | 1.64 |
Interest Coverage | 6.45 |
Quick Ratio
PLYGF
Profitability
Metric | PLYGF |
|---|---|
Return on Assets (Normalized) | 2.06% |
Return on Equity (Normalized) | 4.96% |
Return on Invested Capital (Normalized) | 3.47% |
Return on Assets
PLYGF
Drug Manufacturers - Specialty & Generic Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Merck KGaA ADR MKKGY | LOCK|T>><#h#% | LOCK|?z$Y | $70B | |||
| Teva Pharmaceutical Industries Ltd TEVA | LOCK|QK^g>^&W | LOCK|ksJXm | $47B | |||
| Haleon PLC ADR HLN | LOCK|Y^MmTl | LOCK|?y? | $40B | |||
| Zoetis Inc Class A ZTS | LOCK|%r?<c!$ | LOCK|&r@ | $32B | |||
| Viatris Inc VTRS | LOCK|P@<!J@? | LOCK|Zq& | $23B | |||
| Elanco Animal Health Inc ELAN | LOCK|<% | LOCK|@x | $13B | |||
| Dr Reddy's Laboratories Ltd ADR RDY | LOCK|>&gN%< | LOCK|jP% | $12B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A HIMS | LOCK|&D@y<R | LOCK|fc | $3B | |||
| Prestige Consumer Healthcare Inc PBH | LOCK|mR^&^m^ | LOCK|tXlv | $2B | |||
| Perrigo Co PLC PRGO | LOCK|@W%KW! | LOCK|p% | $2B |